DHRS2 as a Novel Thalidomide Target Regulating Mitophagyand Inflammation in Head and Neck Squamous Cell Carcinoma

CURRENT MEDICINAL CHEMISTRY · Published 2026-07-01 · DOI 10.2174/0109298673457941260609055708

Authors (7)

Yinghui Wu, Qingwen Yao, Yang Li, Zixiao Song, Mei Gan, Jinghua Zhong, Leifeng Liang

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Wu, Y., Yao, Q., Li, Y., et al. (2026). DHRS2 as a Novel Thalidomide Target Regulating Mitophagyand Inflammation in Head and Neck Squamous Cell Carcinoma. CURRENT MEDICINAL CHEMISTRY. https://doi.org/10.2174/0109298673457941260609055708

Related articles

• EGFR Dysregulation in Cancer: From Molecular Mechanisms andKey Mutations to Evolving TKI Strategies and Resistance Mitigation · CURRENT MEDICINAL CHEMISTRY · 2026 · Same journal
• Exploring the Therapeutic Potential of Mangiferin in Promoting Health Span and Stress Tolerance in C. elegans · CURRENT MEDICINAL CHEMISTRY · 2026 · Same journal
• Organ Injury, Protection and Interactions: Novel Targets, Drugs,and Mechanisms · CURRENT MEDICINAL CHEMISTRY · 2026 · Same journal
• Proteome-Wide Mendelian Randomization Identifies Novel Plasma Protein Targets in Osteoarthritis · CURRENT MEDICINAL CHEMISTRY · 2026 · Same journal
• Causal Relationship between Obesity-related Indicators and Major PeripheralVascular Diseases: Two-sample and Multivariate MendelianRandomization Studies · CURRENT MEDICINAL CHEMISTRY · 2026 · Same journal
• Identification of COX7B, GLRX5, and OR52H1 as VascularEndothelial Injury-associated Biomarkers in Gestational DiabetesMellitus · CURRENT MEDICINAL CHEMISTRY · 2026 · Same journal
• Novel Insights into the Causal Effects of Plasma Protein-to-protein Ratios on Aneurysms and the Mediating Effects of Cardiometabolic Traits · CURRENT MEDICINAL CHEMISTRY · 2026 · Same journal
• Biosynthesis of Nimbin and the Metabolic Pathway: A Focus on itsAntiviral Properties · CURRENT MEDICINAL CHEMISTRY · 2026 · Same journal
• Integrating Methylation Signature Modifications and Subtype Classification into a Prognostic Risk Model for Survival Prognosis and Predicting Immunotherapy Response in Colorectal Cancer · CURRENT MEDICINAL CHEMISTRY · 2026 · Same journal
• Knockdown of circFGFR2 inhibits prostate cancer cell metastasis and proliferation by targeting miR-221-5p/ SMUG1 pathway..... · CURRENT MEDICINAL CHEMISTRY · 2026 · Same journal